Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Zhang, Bo; Cheng, Zhifeng; Chen, Ji; Zhang, Xin; Liu, Dexue; Jiang, Hongwei; Ma, Guoqing; Wang, Xiaoyun; Gan, Shenglian; Sun, Juan; Jin, Ping; Yi, Jianjun; Shi, Bimin; Ma, Jianhua; Ye, Shandong; Wang, Guixia; Ji, Linong; Gu, Xuejiang; Yu, Ting; An, Pei; Deng, Huan; Li, Haoyu; Li, Li; Ma, Qingyang; Qian, Lei; Yang, Wenying

doi:10.2337/dc23-1287

Public

Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Shared by NobleBlocks on Jan 1, 2024 • 12:00 AM UTC

Authors:

Bo Zhang

Zhifeng Cheng

Ji Chen

Abstract

OBJECTIVE: We conducted a randomized, double-blind, placebo-controlled phase 2 trial to evaluate the efficacy and safety of mazdutide, a once-weekly glucagon-like peptide 1 and glucagon receptor dual agonist, in Chinese patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Adults with type 2 d...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!